Ann: BIOTRON DRUG EFFECTIVE AGAINST COVID-19 IN ANIMALS, page-164

@Bullrush007 It has a been a big delay. Cannot understand why and very unhappy with that?
BIT225 already has Toxicology approval. (safety for humans)
We sent them the first strike message with the shareholder vote.

The now......
Biotron is back on track.
The BIT225 news with Delta strain is very significant. (new news)

I would be expecting the US to fully fund those trials...or a big pharma.
Fasttrack and emergency approval for treatment against Covid19
is achievable short to midterm.

BIt225 is very advanced stage towards approvals..
This is not any of their other BIT covid19 candidates.

I do not agree with a Class action now?
Pretty hard to win when they have a Blockbuster drug on the doorstep of approval..
BIT225 is very advanced stage.
BIT225 is not an overnight revelation.
There is never going to be a class action....IMO.

And IMO ...this announcement should have happened 1.5 years ago.
...but it is now.

This BIT225 testing against covid19 was in the US.
Not just anyone can do this testing.
If you think covid19 is still a problem for the future, then BIT is looking very good.

Pfiser made about $30 billion in the first year alone with their vax.
But the double jab is only 64% effective now.
Merck and Molnupiravir is only 50% effective but received FDA emergency approval.

The US gov is going to need other treatments.
The whole purpose of the fastrack ...is for this very scenario!
Pandemic....getting certain drugs to market faster ...to save lives.

Fastrack...here we come.
BIT225 is about to fly...again!
Blockbuster....here we come.